JULRI Trademark

Trademark Overview

On Monday, July 14, 2008, a trademark application was filed for JULRI with the United States Patent and Trademark Office. The USPTO has given the JULRI trademark a serial number of 77521523. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 27, 2012. This trademark is owned by Glaxo Group Limited. The JULRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
julri

General Information

Serial Number77521523
Word MarkJULRI
Filing DateMonday, July 14, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 27, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 17, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Monday, August 27, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 27, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2012EXTENSION 5 GRANTED
Tuesday, January 17, 2012EXTENSION 5 FILED
Tuesday, January 17, 2012TEAS EXTENSION RECEIVED
Wednesday, July 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2011EXTENSION 4 GRANTED
Thursday, July 7, 2011EXTENSION 4 FILED
Thursday, July 7, 2011TEAS EXTENSION RECEIVED
Friday, December 17, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 16, 2010EXTENSION 3 GRANTED
Wednesday, December 8, 2010EXTENSION 3 FILED
Wednesday, December 8, 2010TEAS EXTENSION RECEIVED
Thursday, August 12, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 11, 2010EXTENSION 2 GRANTED
Thursday, July 8, 2010EXTENSION 2 FILED
Wednesday, August 11, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 8, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 15, 2009EXTENSION 1 GRANTED
Tuesday, December 15, 2009EXTENSION 1 FILED
Tuesday, December 15, 2009TEAS EXTENSION RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 28, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2009NOTICE OF PUBLICATION
Friday, March 27, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 27, 2009ASSIGNED TO LIE
Thursday, March 26, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 12, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 11, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 5, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 5, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 22, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 22, 2008LETTER OF SUSPENSION E-MAILED
Wednesday, October 22, 2008SUSPENSION LETTER WRITTEN
Wednesday, October 15, 2008ASSIGNED TO EXAMINER
Thursday, July 17, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

julri pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic